When a spinal cord injury has changed how you move, work, sleep, manage bladder or bowel function, or depend on family, it is understandable to keep searching for another path. Some international centers now advertise stem cell therapy alongside neurological care or rehabilitation, but the most important question is not simply “Which clinic offers stem cells?” It is “What exactly is being offered, how strong is the rehabilitation program, what evidence supports the cell therapy, and what happens if I do not improve?” This guide compares six PlacidWay-listed centers patients may encounter while researching SCI care and shows what should be verified before travel.
Quick Summary: What to Check Before Traveling for SCI Stem Cell Therapy
- Stem cell therapy for spinal cord injury remains investigational. A 2026 review found most registered trials were still early- or mid-phase, with late-phase trials uncommon.
- Rehabilitation should be evaluated separately from the cell procedure. Ask whether the center provides SCI-specific physiotherapy, occupational therapy, wheelchair skills, gait training, pressure-care education, bowel/bladder management and long-term functional goals.
- Do not accept “stem cells” as a complete treatment description. Ask for cell source, cell type, donor source, processing method, dose range, route of administration, laboratory standards and regulatory status.
- Current PlacidWay-listed SCI prices are not uniform. Public listings include approximately $8,100 at CellCenter, $12,575 at Vega Stem Cell Clinic and $13,000 at Stem Cells Kyron; other featured centers require an SCI-specific quote or publish prices for different indications.
- Verify the doctor and facility independently. Ask for the physician's current license, facility authorization, ethics/research approval where applicable, and the legal pathway under which the cell product is being used.
- Define success before paying. Walking independently may not be a realistic endpoint for every injury. Meaningful goals can include transfers, trunk control, hand function, wheelchair independence, reduced spasticity, pressure-injury prevention, endurance or self-care.
Why Patients With Spinal Cord Injury Search Beyond Standard Rehabilitation
Many patients begin researching regenerative medicine after standard rehabilitation has reached a plateau or when they are told that further neurological recovery may be limited. The emotional trigger is often not rejection of rehabilitation; it is the fear that the current level of function may become permanent.
That search can become especially intense for people living with paraplegia or tetraplegia, chronic neuropathic pain, spasticity, loss of hand function, sexual dysfunction, bladder or bowel problems, or dependence on caregivers. Families may also be searching because they want to know whether another country is studying or offering approaches unavailable at home.
WHO guidance places multidisciplinary rehabilitation at the center of long-term SCI care. This is important when evaluating a regenerative clinic: the cell procedure should never distract you from the parts of care already known to protect health, independence and participation.
What Patients Should Understand About Stem Cell Therapy for Spinal Cord Injury
Stem cell therapy for spinal cord injury is an active area of research, but it is not an established restorative treatment that can reliably reverse paralysis. Different studies use different cell populations, injury stages, delivery routes and rehabilitation protocols, which makes outcomes difficult to compare.
A 2026 analysis of 80 registered interventional trials found that clinical development remains concentrated in early- and mid-phase studies. Phase III or later trials represented only a small share. That does not mean there is no scientific rationale; it means patients should distinguish research-stage possibility from proven clinical effectiveness.
Questions that turn “stem cell therapy” into a medically meaningful description
| Ask the clinic | Why the answer matters | Red flag |
|---|---|---|
| What exact cell type is used? | MSC, neural progenitor and other cell products are biologically different. | “Premium stem cells” without a scientific cell description. |
| Where do the cells come from? | Autologous, donor-derived and perinatal sources have different processing and oversight considerations. | The clinic will not identify the source. |
| How are the cells processed and tested? | Sterility, identity, viability and manufacturing controls affect product quality. | No written laboratory documentation is available. |
| What route is used? | Intravenous, intrathecal and local delivery are not interchangeable. | A route is presented as universally superior without evidence. |
| What published SCI evidence supports this exact protocol? | Evidence for one cell product cannot automatically be applied to another. | Testimonials are offered instead of clinical evidence. |
How to Tell Whether a Center Offers True SCI Rehabilitation or Mainly a Stem Cell Procedure
A clinic can offer stem cell therapy for spinal cord injury without operating a comprehensive spinal cord rehabilitation program. Patients should evaluate these as two separate capabilities: regenerative treatment and rehabilitation depth.
WHO’s SCI rehabilitation framework includes physical exercise, range-of-motion work, strengthening, balance, gait and mobility training, wheelchair skills, functional hand and arm training, pressure-relief strategies, occupational therapy, psychosocial support and prevention of secondary complications. A short “physiotherapy session” after an infusion is not the same as a multidisciplinary SCI rehabilitation plan.
| Rehabilitation capability | What a serious SCI program should explain | Patient evidence to request |
|---|---|---|
| Neurological baseline | How injury level, completeness and functional deficits are documented. | Neurological examination and recognized functional measures. |
| Physiotherapy | Strengthening, transfers, balance, gait or wheelchair mobility based on ability. | Daily/weekly schedule and therapist credentials. |
| Occupational therapy | Self-care, upper-limb function, equipment and home/community participation. | Named OT services and goals. |
| Secondary complication prevention | Pressure injury, respiratory issues, DVT, spasticity, pain and autonomic dysreflexia planning. | Written prevention and emergency protocols. |
| Assistive technology | Wheelchair seating, braces, standing devices or other equipment when appropriate. | Equipment assessment and training plan. |
| Long-term follow-up | How progress is measured after returning home. | Follow-up schedule and local rehabilitation handoff. |
Six PlacidWay-Listed Centers Patients May Compare for SCI Stem Cell Therapy
The six providers below are the centers specified for this guide. Their PlacidWay profiles or related PlacidWay SCI listings indicate stem-cell or regenerative-medicine services relevant to spinal cord injury, but the public information is not equally detailed for every center.
That difference matters. A listing that confirms “SCI stem cell treatment” does not automatically confirm the intensity of rehabilitation, the regulatory status of a specific cell product, or whether the center can manage complex SCI complications.
| Center | Location | What current PlacidWay information supports | What the SCI patient still needs to verify |
|---|---|---|---|
| MexStemCells Clinic | Mexico City, Mexico | This Mexican stem-cell provider has been identified as a regenerative medicine/stem cell specialist by SCI stem-cell search results. | Exact SCI protocol, cell source, SCI-specific price, rehabilitation schedule, COFEPRIS authorization relevant to the proposed cellular service, and how neurological outcomes are measured. |
| Vega Stem Cell Clinic | Bangkok, Thailand | The center also publishes material describing UC-MSC approaches for SCI. | Legal pathway for the exact cell product, Thai medical/regulatory documentation, evidence supporting the protocol, and whether SCI-specific multidisciplinary rehabilitation is included or arranged separately. |
| GIOSTAR Hospital Bengaluru | Bengaluru, India | It lists spinal cord injuries among regenerative services and includes rehabilitation among the hospital’s specialties. | How any offered SCI cell therapy fits current Indian research/clinical rules, ethics approval where applicable, exact rehabilitation program, admission setting, emergency support and SCI-specific quote. |
| CellCenter - Stem Cell Therapy | Bratislava & Malacky, Slovakia | The profile describes neurological and post-traumatic applications and notes a Malacky location within a hospital building. | Exact product classification and legal pathway, rehabilitation hours, SCI specialist involvement, cell-processing documentation and emergency/hospital backup for the proposed treatment. |
| VISANI® Stem Cells | Puebla, Mexico | The PlacidWay profile includes spinal cord injuries under neurological support and other listed regenerative services, not a verified SCI-specific package. | SCI-specific treatment price, cell protocol, COFEPRIS documentation relevant to the service, rehabilitation depth, neurologic assessment process and follow-up after returning home. |
| Stem Cells Kyron | Cali, Colombia | The provider describes physician-guided regenerative programs for neurological and spinal conditions. | INVIMA/regulatory status of the exact cellular intervention, rehabilitation components, outcome measures, complication plan, laboratory quality records and whether the $13,000 quote includes long-term rehabilitation. |
How Current SCI Stem Cell Prices Compare Across the Featured Centers
Public prices are useful only when the treatment scope is comparable. For three of the six featured providers, PlacidWay currently displays an SCI-specific price. For the others, a current SCI-specific public package price was not clearly supported in the material reviewed, so this guide does not substitute a general stem-cell price.
A quote should separate the cellular intervention from neurological evaluation, rehabilitation, imaging, medicines, anesthesia or procedure fees, hotel accommodation, local transport and emergency care.
| Center | Public SCI-specific price reviewed | Cost interpretation |
|---|---|---|
| CellCenter | $8,100 | Confirm exact cell product, rehabilitation sessions and inclusions. |
| Vega Stem Cell Clinic | $12,575 | Confirm whether the figure covers SCI rehabilitation or primarily the regenerative procedure. |
| Stem Cells Kyron | $13,000 | Confirm rehabilitation, laboratory work, administration route and follow-up inclusions. |
| MexStemCells Clinic | SCI-specific quote required | Do not infer SCI pricing from other condition packages. |
| GIOSTAR Hospital Bengaluru | SCI-specific quote required | Published prices on the profile cover other conditions; request an SCI itemization. |
| VISANI® Stem Cells | SCI-specific quote required | The public $5,500 starting price relates to other listed services and should not be presented as an SCI price. |
What an SCI treatment quote should itemize
- Neurologist or rehabilitation-physician assessment
- MRI or other imaging review and laboratory testing
- Stem-cell procurement, expansion/processing and quality testing
- Administration procedure and anesthesia/sedation if required
- Physiotherapy and occupational therapy hours
- Mobility equipment or assistive-device assessment
- Hospital or observation stay
- Management of complications or emergency transfer
- Accommodation, transport and caregiver costs
- Follow-up consultations and coordination with your home rehabilitation team
How to Verify Regulation and Credentials Before Choosing an SCI Stem Cell Center
A patient should verify three different things: the facility, the doctor and the cell intervention. A licensed clinic does not automatically mean every stem cell therapy product or every claimed indication is authorized.
The regulatory pathway also differs by country. In Mexico, facilities involved in regenerative medicine and specified cell-related activities may require COFEPRIS health-service authorization. Thailand’s Department of Medical Sciences has stated that mesenchymal stem-cell products were not registered with the Thai FDA in the guidance reviewed and described MSC disease treatment as research-oriented under close medical oversight. India’s current evidence-based guidance is especially restrictive for routine SCI stem-cell use.
| Destination | What to verify | Patient question |
|---|---|---|
| Mexico | Relevant COFEPRIS sanitary authorization for the establishment and the proposed cellular activity. | “Please provide the exact license/authorization number that applies to this stem-cell service.” |
| Thailand | Medical license, hospital/clinic authorization, and the legal/research pathway for the cell intervention. | “Under which Thai regulation or approved research protocol is this exact MSC product used for SCI?” |
| India | Physician/facility registration plus research and ethics approvals if stem cells are proposed for SCI. | “How does this treatment comply with current Indian guidance restricting SCI stem-cell therapy to rigorous clinical research?” |
| Slovakia | Facility and physician authorization plus the legal classification and permitted use of the cellular product. | “What is the legal status of this cell product in Slovakia, and which competent authority can verify it?” |
| Colombia | Physician/facility credentials and the INVIMA/regulatory pathway for the proposed advanced therapy. | “Is this product approved, investigational or supplied through another legal pathway, and where is that documented?” |
What Recent Research Says About SCI Stem Cell Trials
The research field is active, but it has not yet reached the level where a clinic can responsibly promise neurological restoration. A 2026 cross-sectional analysis identified 80 interventional stem-cell trials for SCI through the end of 2025.
China accounted for 20 trials, the United States 13, Spain 10, Japan 10 and India 7. Phase I, I/II and II studies dominated the landscape, while phase III or later studies represented only 6.3% of the total. This is why patients should ask providers to separate biological theory, early clinical signals and confirmed benefit.
Selected annual SCI stem-cell trial initiations reported in the 2026 analysis
Source: Wei et al., Frontiers in Neurology, 2026. The paper reports these selected annual counts; the graphic should not be interpreted as a complete year-by-year series.
Countries with the largest numbers of registered SCI stem-cell trials
Source: Wei et al., Frontiers in Neurology, 2026. Counts describe registered interventional trials, not commercial treatment availability or comparative effectiveness.
Which SCI Patients Are Most Likely to Search for Treatment Abroad?
There is no reliable global dataset showing the age, gender and home-country distribution of patients who travel specifically for commercial SCI stem-cell therapy. It would therefore be misleading to invent a medical-tourism demographic profile.
What is known is that SCI affects people with very different injury levels, functional needs and life circumstances. WHO reports that males are more commonly affected than females globally. For medical-travel decision-making, however, injury completeness, time since injury, medical stability, rehabilitation goals, caregiver needs and access barriers are more useful than gender alone.
| Patient situation | Why they may look abroad | What should matter most |
|---|---|---|
| Chronic SCI with plateaued rehabilitation | Search for research-stage regenerative options. | Evidence level, realistic goals and rehabilitation continuation. |
| Incomplete injury with residual motor/sensory function | Hope of improving remaining function. | Baseline testing and objective functional endpoints. |
| Tetraplegia with high caregiver dependence | Even small functional gains could affect daily independence. | Hand/arm function, respiratory safety, transfers and caregiver planning. |
| Patient facing high domestic cost or limited research access | International availability or lower quoted price. | Total trip cost, regulatory status and follow-up at home. |
| Family seeking a “second chance” after being told recovery is limited | Emotional need to explore every possible option. | Independent second opinion and protection from guaranteed-outcome claims. |
What a Safe SCI Rehabilitation Plan Should Look Like Before and After Cell Therapy
If a center proposes cell therapy, the rehabilitation plan should still be built around measurable function and prevention of complications. Patients should know what therapy happens before the procedure, what changes immediately afterward, and what must continue for months at home.
Recovery after SCI is not a single endpoint. A good plan may track transfers, sitting balance, wheelchair mobility, upper-limb function, walking ability when relevant, endurance, pain, spasticity, bowel/bladder routines and participation in daily life.
| Timeframe | Clinical process | Patient sensation | Activity level | Action required |
|---|---|---|---|---|
| Before travel | Medical-record review, neurological baseline and complication screening. | Varies with injury level and current health. | Maintain established rehabilitation unless advised otherwise. | Define measurable goals and confirm candidacy. |
| At destination | Repeat assessment, final treatment decision and rehabilitation evaluation. | Travel fatigue, pain or spasticity may temporarily change performance. | Individualized. | Do not use a travel-day exam as the only baseline. |
| After cell procedure | Monitoring for procedure-related adverse effects and resumption of therapy when cleared. | Depends on administration route and procedure. | Guided by the clinical team. | Report new neurological or systemic symptoms immediately. |
| Weeks to months | Functional rehabilitation and repeated objective measurement. | Progress may be slow, uneven or absent. | Progressive and goal-based. | Continue therapy and compare with baseline rather than relying on impressions. |
| Long term | Ongoing prevention of pressure injury, contractures, pain, respiratory problems and other secondary complications. | Chronic SCI needs change over time. | Maintain fitness and independence safely. | Keep a local SCI physician and rehabilitation team involved. |
Risks and Red Flags Patients Should Discuss Before SCI Stem Cell Therapy
The risks depend on the cell product, manufacturing process and delivery route. They may include infection, immune reactions, procedure-related bleeding or neurological complications, contamination or product-quality problems, and theoretical or known risks related to abnormal cell behavior.
SCI itself also creates travel risk. Pressure injuries, urinary infections, autonomic dysreflexia, respiratory complications, venous thromboembolism and difficulties with transfers or wheelchair access can become more important than the cell procedure if planning is weak.
Questions to Ask Every SCI Stem Cell and Rehabilitation Center Before Booking
Use the same questions with every provider. Consistent questions make it easier to compare medical substance rather than website language.
- What is my neurological diagnosis, injury level and completeness according to your assessment?
- What exact stem-cell product are you proposing, and why for my type of SCI?
- Is the therapy approved for SCI, investigational, or being used under another legal pathway?
- What clinical-trial or published evidence supports this exact product and route?
- What outcome do you consider realistic for someone with my injury and time since injury?
- How do you measure motor, sensory and functional change before and after treatment?
- How many hours of SCI-specific physiotherapy and occupational therapy are included?
- Do you manage bowel/bladder issues, spasticity, pressure injuries, pain and autonomic dysreflexia?
- What are the credentials of the physician performing or supervising the cell intervention?
- Where are the cells processed, and can I review sterility, identity and viability documentation?
- What complications have occurred with this protocol, and how are they managed?
- What is included in the total quote, including rehabilitation and emergency care?
- How long must I remain near the clinic?
- Who follows me after I return home, and what happens if I experience no improvement?
Frequently Asked Questions About SCI Rehabilitation Centers Offering Stem Cell Therapy
Is stem cell therapy proven to restore walking after spinal cord injury?
No stem-cell approach can currently be presented as a reliable way to restore walking for all people with SCI. Research is active, but most trials remain early- or mid-phase. Outcomes vary by injury characteristics, cell product and rehabilitation, so clinics should discuss uncertainty rather than promise recovery.
What is more important: the stem cell procedure or the rehabilitation program?
For established SCI care, structured multidisciplinary rehabilitation is fundamental. If you explore an investigational cell intervention, evaluate the rehabilitation program separately. Ask about physiotherapy, occupational therapy, mobility training, complication prevention, assistive technology and long-term follow-up rather than assuming rehabilitation is included.
How do I compare MexStemCells, Vega, GIOSTAR, CellCenter, VISANI and Stem Cells Kyron?
Compare the exact cell product, regulatory pathway, physician credentials, SCI-specific rehabilitation, public pricing, complication management and follow-up. Public PlacidWay information differs by provider, so no center should be assumed equivalent. Request the same written evidence from each before making a medical or financial decision.
How much does stem cell therapy for spinal cord injury cost abroad?
Current PlacidWay listings reviewed for this guide show approximately $8,100 at CellCenter, $12,575 at Vega Stem Cell Clinic and $13,000 at Stem Cells Kyron. Prices for other featured providers require SCI-specific confirmation. Compare inclusions carefully because rehabilitation and complication care may be separate.
What type of stem cells are being studied for spinal cord injury?
Research has examined several platforms, including mesenchymal stem/stromal cells and neural-lineage cell products. A 2026 global trial review found mesenchymal cells were the predominant platform. However, evidence from one cell type cannot automatically validate another clinic's product, dose or delivery method.
What rehabilitation services should an SCI center provide?
A comprehensive program may include strength and range-of-motion training, balance, transfers, gait or wheelchair mobility, upper-limb function, occupational therapy, pressure relief, pain and spasticity management, respiratory care, assistive technology, psychosocial support and prevention of secondary complications.
How can I verify a stem cell clinic in Mexico?
Ask the clinic for the exact COFEPRIS health-service license or authorization relevant to its regenerative-medicine or cellular activities. Verify the physician separately and ask what authorization applies to the exact cell product and SCI indication. A general clinic license should not be treated as proof of efficacy.
Can stem cell therapy for SCI be offered routinely in India?
Current Indian evidence-based guidance is restrictive. The 2025 neurological guideline states that stem cell therapy is not recommended for routine SCI treatment and may be used only in rigorously conducted randomized controlled trials. Patients should ask any Indian provider how the proposed intervention complies with current requirements.
What outcomes should I track after treatment?
Track objective functional outcomes agreed before treatment. Depending on your injury, these may include motor or sensory scores, hand function, trunk control, transfers, wheelchair skills, walking measures, spasticity, pain, bladder or bowel function and independence in daily activities. Avoid judging results only by temporary sensations.
Should I stop conventional rehabilitation if I receive stem cell therapy abroad?
Do not stop established rehabilitation without discussing it with your qualified SCI team. Rehabilitation remains a core part of SCI management. Any experimental or regenerative intervention should be integrated with safe functional training, complication prevention and ongoing medical care rather than positioned as a replacement.
Compare SCI Stem Cell and Rehabilitation Options With PlacidWay
PlacidWay can help you compare provider information, request current SCI-specific pricing, organize questions for clinics and understand what each program says it includes. Before choosing a center, ask for a medical review of your injury, written treatment details, rehabilitation schedule, regulatory documentation and follow-up plan.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider before making medical decisions.
References
- Spinal Cord Injury – World Health Organization
- Package of Interventions for Rehabilitation: Module 3, Neurological Conditions – World Health Organization
- Global Landscape of Registered Clinical Trials of Stem Cell Therapy for Spinal Cord Injury – Frontiers in Neurology
- Guidelines for Stem Cell Research and Clinical Translation, 2025 Update – International Society for Stem Cell Research
- Evidence-Based Guidelines for the Use of Stem Cell Therapy: Neurological Conditions – Department of Health Research, Government of India
- Establecimientos de Servicios de Salud – COFEPRIS, Government of Mexico
- Stem Cell Information and Medical Use Guidance – Department of Medical Sciences, Thailand Ministry of Public Health
.png)
.png)
.png)
.png)
.png)
.png)
.jpg)
Share this listing